
This is not a complete list of all the fluoroquinolones currently in use today. The number of fluoroquinolones including generic equivalents is well into the thousands, with various manufacturers using their own trademark names for the very same drug. The following is a list of the various chemical names that make up this chemotherapeutic class of drugs. Again this is far from being an exhaustive list of such agents as new drugs are being developed all over the world:
Fluoroquinolones are a group of synthetic antibiotics that are derived from
basic structure of nalidixic acid and have substituents at N-1, C-5, C-7,
position 8 and a fluorine atom at position 6. There are also polycyclic
derivatives. Quinolone antibiotics have a ketone at position 4 and a carboxylic
group at position 3. Fluoroquinolones inhibit the bacterial DNA gyrase or the
topoisomerase IV enzyme, resulting the inhibition of DNA replication and
transcription. Fluorine at position 6 enhances gyrase inhibition and cell
penetration. Piperaziny substituents provide activity against Gram-negative
bacteria and pyrrolidinyl moiety is active against Gram-positive cocci. They
improve water solubility needed oral application. The function substituted at
position 8 IS to control anaerobe activity.
Fluoroquinolone Substituted at N-1
Alumofloxacin No information available
Amifloxacin
Balofloxacin
Ciprofloxacin
Still in use in spite of fatal reactions, peripheral neuropathy / tendon ruptures
Difloxacin Veterinarian
use no further information available
Ecenofloxacin Chemos GmbH No information
available
Enoxacin
Fleroxacin
Not available for clinical use in several European countries and the USA.
Gemifloxacin
Still in use in spite of disfiguring rashes
Grepafloxacin
Removed from Clinical Use due to heart problems
Lomefloxacin Still in use in spite of irreversible peripheral neuropathy / tendon ruptures
Moxifloxacin
Still in use in spite of fatal reactions, peripheral neuropathy /
tendon ruptures
Norfloxacin
Temafloxacin Removed from Clinical Use
Trovafloxacin
Removed from Clinical Use due to fatal liver failures
Substituted at C-5
Grepafloxacin
Removed from Clinical Use due to heart problems
Sparfloxacin
Associated with rhabdomyolysis
Substituted at C-7
Balofloxacin
Clinafloxacin
Removed from Clinical Use due to severe phototoxicity and hypoglycemia
Ciprofloxacin
Still in use in spite of fatal reactions, peripheral neuropathy / tendon
ruptures
Danafloxacin
Veterinarian use no further information available
Fleroxacin
Not available for clinical use
in several European countries and the USA.
Garenoxacin Schering
Gatifloxacin
No longer being manufactured due to severe and fatal hypo/hyperglycemia
Grepafloxacin
Removed from Clinical Use due to
fatal reactions, heart problems
Irloxacin
Levofloxacin
Still in use in spite of fatal reactions, peripheral neuropathy / tendon ruptures
Lomefloxacin
Still in use in spite of irreversible peripheral neuropathy / tendon ruptures
Moxifloxacin
Still in use in spite of fatal reactions, peripheral
neuropathy / tendon ruptures
Nadifloxacin
Norfloxacin
Ofloxacin
Discontinued no reason given
Piperidiny
Sitafloxacin
Sparfloxacin
Associated with
rhabdomyolysis
Trovafloxacin
Removed from Clinical Use due to fatal liver problems
Substituted at position 8
Alatrofloxacin (TROVAN)
Still in use in spite of fatal
liver problems
Balofloxacin
Ciprofloxacin
Still in use in spite of fatal reactions, peripheral neuropathy / tendon ruptures
Clinafloxacin
Removed from Clinical Use due to severe phototoxicity and hypoglycemia
Ecenofloxacin No information available
Enoxacin
Fleroxacin
Not available for clinical use in several European countries and the USA.
Garenoxacin
Gatifloxacin
No longer being manufactured due to severe and fatal hypo/hyperglycemia
Gemifloxacin
Still in use in spite of disfiguring rashes
Grepafloxacin
Removed from
Clinical Use due to heart problems
Lomefloxacin
Still in use in spite of irreversible peripheral neuropathy / tendon ruptures
Moxifloxacin Still in use
in spite of fatal reactions, peripheral neuropathy / tendon
ruptures
Norfloxacin
Pazufloxacin
Pefloxacin
Not available in USA, Not FDA approved
Sitafloxacin
Sparfloxacin
Associated with rhabdomyolysis
Temafloxacin Removed
from Clinical Use
Tosufloxacin
Associated with chronic interstitial nephritis
Trovafloxacin
Removed from Clinical Use due to fatal liver problems
Tricyclic derivatives
Abufloxacin
Droxacin
Flumequine
Still in use in spite of being direct acting genotoxic carcinogen
Levofloxacin
Still in use in spite of fatal reactions, peripheral neuropathy / tendon ruptures
Marbofloxacin
Miloxacin
Ofloxacin
Discontinued no reason given
Oxolinic acid
Pazufloxacin
Prulifloxacin
Rufloxacin
Verbafloxacin
QUINOLONES (Non-fluorinated)
Cinoxacin 28657-80-9
Discontinued no reason given
Mictral 79449-95-9
Miloxacin 37065-29-5
Nalidixic acid 389-08-2
Discontinued cancer causing agent
Nalidixate sodium anhydrous 3374-05-8
Nalidixate sodium 15769-77-4
Oxolinic acid 14698-29-4
Pipemidic acid 51940-44-4
Piromidic acid 19562-30-2
Rosoxacin 40034-42-2 Usage
restricted to gonorrhea
FLUOROQUINOLONES (fluorinated)
Alatrofloxacin 157182-32-6
Amifloxacin 86393-37-5
Balofloxacin 127294-70-6
Ciprofloxacin 85721-33-1 Still in use
in spite of fatal reactions, peripheral neuropathy / tendon ruptures
Clinafloxacin 105956-97-6 Removed from Clinical Use
due to severe phototoxicity and hypoglycemia
Danofloxacin 112398-08-0
Veterinarian use no further information available
Difloxacin 98106-17-3
Veterinarian use no further information available
Ecenofloxacin 162301-05-5 No information available
Enoxacin 74011-58-8
Enrofloxacin
93106-60-6 Banned by
the FDA
Fleroxacin 79660-72-3
Not available for clinical use in several European countries and
the USA.
Flumequine 42835-25-6 Still
in use in spite of being direct acting genotoxic carcinogen
Gatifloxacin
112811-59-3 No longer being manufactured due to
severe and fatal hypo/hyperglycemia
Gemifloxacin 175463-14-6 Still
in use in spite of disfiguring rashes
Grepafloxacin 119914-60-2 Removed from Clinical Use
due to fatal heart problems
Levofloxacin
100986-85-4 Still in use: fatal reactions, peripheral neuropathy / tendon ruptures
Lomefloxacin 98079-51-7
Still in use in spite of peripheral neuropathy / tendon ruptures
Marbofloxacin 115550-35-1
Moxifloxacin 151096-09-2 Still in use:
fatal reactions, peripheral neuropathy / tendon ruptures
Nadifloxacin 124858-35-1
Norfloxacin 70458-96-7
Ofloxacin
82419-36-1
No longer being manufactured no reason given
Orbifloxacin 113617-63-3
Pazufloxacin 127045-41-4
Pefloxacin 70458-92-3
Not available in USA, Not FDA approved
Prulifloxacin 123447-62-1 Optimer
Rufloxacin 101363-10-4
Sarafloxacin 98105-99-8
Sitafloxacin 127254-12-0
Sparfloxacin 110871-86-8
Associated with rhabdomyolysis
Temafloxacin 108319-06-8
Removed from Clinical Use
Tosufloxacin 100490-36-6 Associated
with chronic interstitial nephritis
Trovafloxacin 147059-72-1 Removed from Clinical Use
due to fatal liver problems
** Note: Lack of information found on the FDA site may be for several
reasons including
the drug being removed from clinical practice, different name, or
veterinarian use.